0001140361-18-032341.txt : 20180713
0001140361-18-032341.hdr.sgml : 20180713
20180713133651
ACCESSION NUMBER: 0001140361-18-032341
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180711
FILED AS OF DATE: 20180713
DATE AS OF CHANGE: 20180713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sofia Michael J.
CENTRAL INDEX KEY: 0001635324
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 18952180
MAIL ADDRESS:
STREET 1: C/O ONCORE BIOPHARMA, INC.
STREET 2: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arbutus Biopharma Corp
CENTRAL INDEX KEY: 0001447028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980597776
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
BUSINESS PHONE: 604-419-3200
MAIL ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp
DATE OF NAME CHANGE: 20110607
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20081003
4
1
doc1.xml
FORM 4
X0306
4
2018-07-11
0
0001447028
Arbutus Biopharma Corp
ABUS
0001635324
Sofia Michael J.
C/O ARBUTUS BIOPHARMA CORP.
SUITE 100, 8900 GLENLYON PARKWAY
BURNABY
A1
V5J 5J8
BRITISH COLUMBIA, CANADA
0
1
0
0
Chief Scientific Officer
Common Shares
2018-07-11
4
S
0
10000
10.00
D
1503403
D
Common Shares
171412
I
Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 22, 2014
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017.
/s/ David C. Hastings, attorney-in-fact for Michael J. Sofia
2018-07-13